FAT1 mutation-related signature predicts survival risk and tumor immunogenicity in lung adenocarcinoma.

Front Genet · 2025 · PMC12263358 · PMID 40672387

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

did not reach statistical significanceP = 0.093so close (0.05 < p ≤ 0.1)

In the ICB cohort 2, we observed that low-risk individuals still exhibited improved immune therapy prognosis, although this result did not reach statistical significance (Log-rank test, P = 0.093; Figure 8F ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.